ICD-10-CM Diagnosis Code T36.4X5 - Adverse effect of tetracyclines (original) (raw)
ICD List 2025-2026 Edition
- Home
- ICD-10-CM Codes
- S00–T88
- T36-T50
- T36
- 2026 ICD-10-CM Code T36.4X5
Adverse effect of tetracyclines
ICD-10-CM Code:
T36.4X5
ICD-10 Code for:
Adverse effect of tetracyclines
Is Billable?
Not Valid for Submission
Code Navigator:
T36.4X5 is a non-specific and non-billable diagnosis code code, consider using a code with a higher level of specificity from the list below for a diagnosis of adverse effect of tetracyclines. The code is not specific and is NOT valid for the year 2026 for the submission of HIPAA-covered transactions. Category or Header define the heading of a category of codes that may be further subdivided by the use of 4th, 5th, 6th or 7th characters.
Non-specific codes like T36.4X5 require more digits to indicate the appropriate level of specificity. Consider using any of the following billable codes with a higher level of specificity when coding for adverse effect of tetracyclines:
Use T36.4X5A for initial encounter
Use T36.4X5D for subsequent encounter
Use T36.4X5S for sequela
- Code Information
- Specific Coding
- Approximate Synonyms
- Clinical Information
- Coding Guidelines
- Tabular List of Diseases and Injuries
- Table of Drugs and Chemicals
- Patient Education
- Other Codes Used Similar Conditions
- Code History
- Injury, poisoning and certain other consequences of external causes
S00–T88
The following list of clinical terms are approximate synonyms, alternative descriptions, or common phrases that might be used by patients, healthcare providers, or medical coders to describe the same condition. These synonyms and related diagnosis terms are often used when searching for an ICD-10 code, especially when the exact medical terminology is unclear. Whether you're looking for lay terms, similar diagnosis names, or common language alternatives, this list can help guide you to the correct ICD-10 classification.
Adverse reaction to clomocycline
Chemical esophagitis
Chlortetracycline adverse reaction
Color changes during tooth formation
Demeclocycline adverse reaction
Doxycycline adverse reaction
Esophagitis medicamentosa
Intrinsic staining of tooth - drug-induced
Intrinsic staining of tooth caused by tetracycline
Lymecycline adverse reaction
Minocycline adverse reaction
Oxytetracycline adverse reaction
Pill esophagitis
Pill esophagitis caused by tetracycline
Posteruptive color change of tooth
Posteruptive tooth staining caused by drug
Posteruptive tooth staining caused by tetracycline
Pre-eruptive color change of tooth
Tetracycline adverse reaction
Tetracyclines group adverse reaction
Chlortetracycline
a tetracycline with a 7-chloro substitution.
Demeclocycline
a tetracycline analog having a 7-chloro and a 6-methyl. because it is excreted more slowly than tetracycline, it maintains effective blood levels for longer periods of time.
Doxycycline
a synthetic tetracycline derivative with similar antimicrobial activity.
Lymecycline
a semisynthetic antibiotic related to tetracycline. it is more readily absorbed than tetracycline and can be used in lower doses.
Methacycline
a broad-spectrum semisynthetic antibiotic related to tetracycline but excreted more slowly and maintaining effective blood levels for a more extended period.
Minocycline
a tetracycline analog, having a 7-dimethylamino and lacking the 5 methyl and hydroxyl groups, which is effective against tetracycline-resistant staphylococcus infections.
Oxytetracycline
a tetracycline analog isolated from the actinomycete streptomyces rimosus and used in a wide variety of clinical conditions.
Rolitetracycline
a pyrrolidinylmethyl tetracycline.
Tetracycline
a naphthacene antibiotic that inhibits amino acyl trna binding during protein synthesis.
Tetracycline Resistance
nonsusceptibility of bacteria to the action of tetracycline which inhibits aminoacyl-trna binding to the 30s ribosomal subunit during protein synthesis.
Tetracyclines
closely congeneric derivatives of the polycyclic naphthacenecarboxamide. (gilman et al., goodman and gilman's the pharmacological basis of therapeutics, 8th ed, p1117)
When coding an adverse effect of a drug that has been correctly prescribed and properly administered, assign the appropriate code for the nature of the adverse effect followed by the appropriate code for the adverse effect of the drug.
The appropriate 7th character is to be added to each code from block Poisoning by, adverse effect of and underdosing of systemic antibiotics (T36). Use the following options for the aplicable episode of care:
- A - initial encounter
- D - subsequent encounter
- S - sequela
The code is referenced in the Table of Drugs and Chemicals, this table contains a classification of drugs, industrial solvents, corrosive gases, noxious plants, pesticides, and other toxic agents.
According to ICD-10-CM coding guidelines it is advised to do not code directly from the Table of Drugs and Chemicals, instead always refer back to the Tabular List when doing the initial coding. Each substance in the table is assigned a code according to the poisoning classification and external causes of adverse effects. It is important to use as many codes as necessary to specify all reported drugs, medicinal or chemical substances. If the same diagnosis code describes the causative agent for more than one adverse reaction, poisoning, toxic effect or underdosing, utilize the code only once.
Filter table of drugs and chemicals:
| Substance | Poisoning Accidental (unintentional) | Poisoning Accidental (self-harm) | Poisoning Assault | Poisoning Undetermined | Adverse effect | Underdosing |
|---|---|---|---|---|---|---|
| Achromycin | T36.4X1 | T36.4X2 | T36.4X3 | T36.4X4 | T36.4X5 | T36.4X6 |
| Achromycin »ophthalmic preparation | T36.4X1 | T36.4X2 | T36.4X3 | T36.4X4 | T36.4X5 | T36.4X6 |
| Achromycin »topical NEC | T36.4X1 | T36.4X2 | T36.4X3 | T36.4X4 | T36.4X5 | T36.4X6 |
| Aureomycin | T36.4X1 | T36.4X2 | T36.4X3 | T36.4X4 | T36.4X5 | T36.4X6 |
| Aureomycin »ophthalmic preparation | T36.4X1 | T36.4X2 | T36.4X3 | T36.4X4 | T36.4X5 | T36.4X6 |
| Aureomycin »topical NEC | T36.4X1 | T36.4X2 | T36.4X3 | T36.4X4 | T36.4X5 | T36.4X6 |
| Chlormethylenecycline | T36.4X1 | T36.4X2 | T36.4X3 | T36.4X4 | T36.4X5 | T36.4X6 |
| Chlortetracycline | T36.4X1 | T36.4X2 | T36.4X3 | T36.4X4 | T36.4X5 | T36.4X6 |
| Clomocycline | T36.4X1 | T36.4X2 | T36.4X3 | T36.4X4 | T36.4X5 | T36.4X6 |
| Declomycin | T36.4X1 | T36.4X2 | T36.4X3 | T36.4X4 | T36.4X5 | T36.4X6 |
| Demeclocycline | T36.4X1 | T36.4X2 | T36.4X3 | T36.4X4 | T36.4X5 | T36.4X6 |
| Demethylchlortetracycline | T36.4X1 | T36.4X2 | T36.4X3 | T36.4X4 | T36.4X5 | T36.4X6 |
| Demethyltetracycline | T36.4X1 | T36.4X2 | T36.4X3 | T36.4X4 | T36.4X5 | T36.4X6 |
| DMCT | T36.4X1 | T36.4X2 | T36.4X3 | T36.4X4 | T36.4X5 | T36.4X6 |
| Doxycycline | T36.4X1 | T36.4X2 | T36.4X3 | T36.4X4 | T36.4X5 | T36.4X6 |
| Guamecycline | T36.4X1 | T36.4X2 | T36.4X3 | T36.4X4 | T36.4X5 | T36.4X6 |
| Lymecycline | T36.4X1 | T36.4X2 | T36.4X3 | T36.4X4 | T36.4X5 | T36.4X6 |
| Meclocycline | T36.4X1 | T36.4X2 | T36.4X3 | T36.4X4 | T36.4X5 | T36.4X6 |
| Metacycline | T36.4X1 | T36.4X2 | T36.4X3 | T36.4X4 | T36.4X5 | T36.4X6 |
| Methacycline | T36.4X1 | T36.4X2 | T36.4X3 | T36.4X4 | T36.4X5 | T36.4X6 |
| Minocycline | T36.4X1 | T36.4X2 | T36.4X3 | T36.4X4 | T36.4X5 | T36.4X6 |
| Oxytetracycline | T36.4X1 | T36.4X2 | T36.4X3 | T36.4X4 | T36.4X5 | T36.4X6 |
| Penimepicycline | T36.4X1 | T36.4X2 | T36.4X3 | T36.4X4 | T36.4X5 | T36.4X6 |
| Polycycline | T36.4X1 | T36.4X2 | T36.4X3 | T36.4X4 | T36.4X5 | T36.4X6 |
| Rolitetracycline | T36.4X1 | T36.4X2 | T36.4X3 | T36.4X4 | T36.4X5 | T36.4X6 |
| Terramycin | T36.4X1 | T36.4X2 | T36.4X3 | T36.4X4 | T36.4X5 | T36.4X6 |
| Tetracycline | T36.4X1 | T36.4X2 | T36.4X3 | T36.4X4 | T36.4X5 | T36.4X6 |
| Tetracycline »ophthalmic preparation | T36.4X1 | T36.4X2 | T36.4X3 | T36.4X4 | T36.4X5 | T36.4X6 |
| Tetracycline »topical NEC | T36.4X1 | T36.4X2 | T36.4X3 | T36.4X4 | T36.4X5 | T36.4X6 |
Drug Reactions
Most of the time, medicines make our lives better. They reduce aches and pains, fight infections, and control problems such as high blood pressure or diabetes. But medicines can also cause unwanted reactions, such as drug interactions, side effects, and allergies.
What is a drug interaction?
A drug interaction is a change in the way a drug acts in the body when taken with certain other drugs, foods, or supplements or when taken while you have certain medical conditions. Examples include:
- Two drugs, such as aspirin and blood thinners
- Drugs and food, such as statins and grapefruit
- Drugs and supplements, such as gingko and blood thinners
- Drugs and medical conditions, such as aspirin and peptic ulcers
Interactions could cause a drug to be more or less effective, cause side effects, or change the way one or both drugs work.
What are side effects?
Side effects are unwanted, usually unpleasant, effects caused by medicines. Most are mild, such as a stomachache, dry mouth, or drowsiness, and go away after you stop taking the medicine. Others can be more serious. Sometimes a drug can interact with a disease that you have and cause a side effect. For example, if you have a heart condition, certain decongestants can cause you to have a rapid heartbeat.
What are drug allergies?
Drug allergies are another type of reaction. They can range from mild to life-threatening. Skin reactions, such as hives and rashes, are the most common type. Anaphylaxis, a serious allergic reaction, is less common.
How can I stay safe when taking medicines?
When you start a new prescription or over-the-counter medicine, make sure you understand how to take it correctly. Know which other medicines, foods, and supplements you need to avoid. Always talk to your health care provider or pharmacist if you have questions about your medicines.
FY 2026 - No Change, effective from 10/1/2025 through 9/30/2026
FY 2025 - No Change, effective from 10/1/2024 through 9/30/2025
FY 2024 - No Change, effective from 10/1/2023 through 9/30/2024
FY 2023 - No Change, effective from 10/1/2022 through 9/30/2023
FY 2022 - No Change, effective from 10/1/2021 through 9/30/2022
FY 2021 - No Change, effective from 10/1/2020 through 9/30/2021
FY 2020 - No Change, effective from 10/1/2019 through 9/30/2020
FY 2019 - No Change, effective from 10/1/2018 through 9/30/2019
FY 2018 - No Change, effective from 10/1/2017 through 9/30/2018
FY 2017 - No Change, effective from 10/1/2016 through 9/30/2017
FY 2016 - New Code, effective from 10/1/2015 through 9/30/2016. This was the first year ICD-10-CM was implemented into the HIPAA code set.
